INDOCO REMEDIES has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Sep-18* | 3 Jun-19* | 3 Sep-19* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 2,356 | 2,527 | 2,920 | 15.6% | 23.9% |
Other income | Rs m | 3 | 6 | 6 | -9.4% | 75.8% |
Turnover | Rs m | 2,360 | 2,533 | 2,926 | 15.5% | 24.0% |
Expenses | Rs m | 2,238 | 2,299 | 2,598 | 13.0% | 16.1% |
Gross profit | Rs m | 118 | 228 | 321 | 41.3% | 172.1% |
Depreciation | Rs m | 177 | 170 | 180 | 6.2% | 2.2% |
Interest | Rs m | 50 | 61 | 54 | -12.3% | 7.2% |
Profit before tax | Rs m | -105 | 3 | 93 | 3225.0% | |
Tax | Rs m | -27 | -19 | 20 | ||
Profit after tax | Rs m | -78 | 22 | 73 | 236.2% | |
Gross profit margin | % | 5.0 | 9.0 | 11.0 | ||
Effective tax rate | % | 26.0 | -678.6 | 21.3 | ||
Net profit margin | % | -3.3 | 0.9 | 2.5 |
To see how INDOCO REMEDIES has performed over the last eight quarters,please visit here.
Urgent New Alert: About Coming Once-in-a-generation Wealth Shift
Over the last one year,INDOCO REMEDIES share price has moved down from Rs 184.6 to Rs 161.0, registering a Loss of Rs 23.6 or around 12.8%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,336.2 (up 0.1%). Over the last one year it has moved down from 14,469.9 to 13,336.2, a gain of 1,134 points (down 7.8%).
Overall, the S&P BSE SENSEX is up 15.4% over the year.
At the current price of Rs 161.0, the price to earnings (P/E) ratio of INDOCO REMEDIES stands at 56.0 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.2 times.
For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.
For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.
More Views on NewsIn this video, I'll tell you why I am recommending caution in the market at this time.
A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.
In this video I'll show you exactly how I go about picking stocks for trading.
100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.
More
| |
Equitymaster requests your view! Post a comment on "INDOCO REMEDIES Announces Quarterly Results (2QFY20); Net Profit Up 194.1%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!